Canada markets closed

SOHM, Inc. (SHMN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00120.0000 (0.00%)
At close: 03:12PM EDT

SOHM, Inc.

4740 Green River Road
Suite 307
Corona, CA 92880
United States
714-522-6700
https://www.sohm.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees145

Key Executives

NameTitlePayExercisedYear Born
Mr. Shailesh ShahChairman, CEO, President, CEO of US, India & Global Ops and President of US, India & Global OpsN/AN/A1966
Dr. David Aguliar Ph.D.Chief Operating OfficerN/AN/AN/A
Ms. Swati ShahVice President, Secretary, Treasurer and DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.

Corporate Governance

SOHM, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.